Skip to content
Catalyst

PapersPMID:39792585

A creatine efflux transporter in oligodendrocytes.

The FEBS journal2025The record ↗

  1. Finding, insufficient evidenceraisesSLC22A15

What moved

1 findingHow to read these marks →
  • “Our findings establish SLC22A15 as the pivotal transporter for controlled creatine release from oligodendrocytes, filling a critical gap in understanding creatine metabolism in the brain.”
    Study
    in vitro · not in humans
    Population
    HEK293 cells heterologously expressing human and rat SLC22A15

Study record

Design
in vitro / mechanistic study
Species
cells
Population
HEK293 (293) cells heterologously expressing human and rat SLC22A15
Participants
not reported
Comparator
none
Duration
not reported
Endpoints measured
1